Detalles de la búsqueda
1.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462870
2.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med
; 19(1): 270, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34167578
3.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474768
4.
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
J Transl Med
; 17(1): 376, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31730009
5.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
BJU Int
; 123(1): 98-105, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29956884
6.
Medical oncologist's commitment in end-of-life care of cancer patients.
Palliat Support Care
; 12(5): 351-4, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23768912
7.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38489861
8.
Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy.
Cancers (Basel)
; 15(13)2023 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444451
9.
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Clin Cancer Res
; 29(14): 2714-2724, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37125965
10.
The Remapping of Peripersonal Space in a Real but Not in a Virtual Environment.
Brain Sci
; 12(9)2022 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36138861
11.
Tool-use Extends Peripersonal Space Boundaries in Schizophrenic Patients.
Schizophr Bull
; 48(5): 1085-1093, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35708490
12.
Biallelic variants in TAMM41 are associated with low muscle cardiolipin levels, leading to neonatal mitochondrial disease.
HGG Adv
; 3(2): 100097, 2022 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321494
13.
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy.
Thorac Cancer
; 13(3): 483-488, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34939342
14.
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
J Hematol Oncol
; 15(1): 9, 2022 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35062993
15.
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Eur J Cancer
; 148: 24-35, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721704
16.
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Thorac Cancer
; 12(6): 880-889, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33527756
17.
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.
J Immunother Cancer
; 9(4)2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827906
18.
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.
Eur J Cancer
; 142: 18-28, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33212418
19.
Triple-negative breast cancer: current state of the art.
Tumori
; 96(6): 875-88, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21388048
20.
A novel, pathogenic dinucleotide deletion in the mitochondrial MT-TY gene causing myasthenia-like features.
Neuromuscul Disord
; 30(8): 661-668, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32684384